Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.21K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rebus Holdings, Inc.Rebus Holdings, Inc.0--10%--0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3,213.00
Enterprise Value$308,213.00
Earnings per Share$-0.03
Beta10
Outstanding Shares32,132,907

Return

Return on Equity-10.16%ROE
Return on Assets6333.33%
Return on Invested Capital-10.57%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.52
Enterprise Value to Net Income0
Total Debt to Enterprise1.01
Debt to Equity-0.06Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Rebus Holdings, Inc.

1 employees
CEO: Raul Silvestre

Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerou...